CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Observation onlyWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (0)


Name (Synonyms) Correlation

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19

This is a protocol-driven observational study of lung ultrasound and focused echocardiography images obtained in the Emergency Department (ED) and Intensive Care Unit (ICU) settings as a part of existing standard of care. The objectives of this study are as follows: 1. To characterize various clinical and cardiopulmonary ultrasound findings and describe their relationship with the clinical course of patients with COVID-19 in the ED and ICU. 2. To describe, develop, and validate a prediction tool that can accurately predict the need for invasive mechanical ventilation (IMV) and acute respiratory failure in COVID-19 patients using clinical, laboratory, and ultrasound data.

NCT04379544 Coronavirus Respiratory Failure Other: Observation only
MeSH:Respiratory Insufficiency

Primary Outcomes

Description: Number of patients requiring invasive mechanical ventilation and suffers from acute respiratory failure.

Measure: Patient requires invasive mechanical ventilation and suffers from acute respiratory failure.

Time: 1 Year

Description: Number of patients that do not require hospitalization and is able to safely recover from COVID-19 at home.

Measure: Patient is discharged

Time: 1 Year

Description: Number of patients that must be hospitalized to recover from COVID-19, but does not require invasive mechanical ventilation and may or may not suffer from some degree of acute respiratory failure.

Measure: Patient is hospitalized, but does not require mechanical ventilation through the duration of hospital stay.

Time: 1 Year

Secondary Outcomes

Description: Any lung ultrasound findings including, but not limited to b-lines, a-lines, consolidations, pleural effusions and regularities. All of these findings are consolidated to a single score which will be the measure of the severity of lung ultrasound findings.

Measure: Lung ultrasound findings

Time: 1 year

Description: Any cardiac ultrasound findings including, but not limited to IVC status, pericardial effusions, LV EF (%), RV function. All of these findings are consolidated to a single score which will be the measure of the severity of cardiac ultrasound findings.

Measure: Cardiac ultrasound findings

Time: 1 year


No related HPO nodes (Using clinical trials)